1. Application of Machine Learning in Drug Development and Regulation: Current Status and Future Potential. Issue 4 (8th February 2020) Authors: Liu, Qi; Zhu, Hao; Liu, Chao; Jean, Daphney; Huang, Shiew‐Mei; ElZarrad, M. Khair; Blumenthal, Gideon; Wang, Yaning Journal: Clinical pharmacology & therapeutics Issue: Volume 107:Issue 4(2020) Page Start: 726 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of benefits and risks in development of targeted therapies for cancer — The view of regulatory authorities. Issue 5 (16th October 2014) Authors: Pignatti, Francesco; Jonsson, Bertil; Blumenthal, Gideon; Justice, Robert Other Names: Mendelsohn John specialEditor.; Ringborg Ulrik specialEditor.; Schilsky Richard specialEditor. Journal: Molecular oncology Issue: Volume 9:Issue 5(2015:May) Page Start: 1034 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non‐Small Cell Lung Cancers Harboring BRAF V600E Mutations. (7th February 2018) Authors: Odogwu, Lauretta; Mathieu, Luckson; Blumenthal, Gideon; Larkins, Erin; Goldberg, Kirsten B.; Griffin, Norma; Bijwaard, Karen; Lee, Eunice Y.; Philip, Reena; Jiang, Xiaoping; Rodriguez, Lisa; McKee, Amy E.; Keegan, Patricia; Pazdur, Richard Journal: Oncologist Issue: Volume 23:Number 6(2018) Page Start: 740 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy. (16th March 2016) Authors: Kazandjian, Dickran; Suzman, Daniel L.; Blumenthal, Gideon; Mushti, Sirisha; He, Kun; Libeg, Meredith; Keegan, Patricia; Pazdur, Richard Journal: Oncologist Issue: Volume 21:Number 5(2016) Page Start: 634 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non‐Small Cell Lung Cancer With Progression On or After Platinum‐Based Chemotherapy. (16th March 2016) Authors: Kazandjian, Dickran; Suzman, Daniel L.; Blumenthal, Gideon; Mushti, Sirisha; He, Kun; Libeg, Meredith; Keegan, Patricia; Pazdur, Richard Journal: Oncologist Issue: Volume 21:Number 5(2016) Page Start: 634 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Older adults in hematologic malignancy trials: Representation, barriers to participation and strategies for addressing underrepresentation. (September 2020) Authors: Kanapuru, Bindu; Singh, Harpreet; Kwitkowski, Virginia; Blumenthal, Gideon; Farrell, Ann T.; Pazdur, Richard Journal: Blood reviews Issue: Volume 43(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗